Athira Pharma Announces Appointment of Mark Litton as Chief Operating Officer

Published: 11/07/2019
Athira Pharma Announces Appointment of Mark Litton as Chief Operating Officer
Source: WWW.PRNEWSWIRE.COM

SEATTLE, July 11, 2019 /PRNewswire/ -- Athira Pharma, Inc., a clinical-stage company dedicated to developing therapies for Alzheimer's and Parkinson's, today announced the appointment of Mark Litton, PhD, MBA as Chief Operating Officer. "Mark has tremendous experience in the operations...

Read more
Related news
Comment
FACEBOOK